| RS2515401 |
IL36RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized pustular psoriasis, Acrodermatitis continua suppurativa of Hallopeau |
| RS2515402 |
IL36RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized pustular psoriasis, Acrodermatitis continua suppurativa of Hallopeau |
| RS2515403750 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5C |
| RS2515403962 |
TNNT1
|
Health Risk |
Pathogenic |
Nemaline myopathy 5B, autosomal recessive |
| RS2515404859 |
TNNT1
|
Health Risk |
Pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS2515417949 |
TTI1
|
Health Risk |
Pathogenic |
Severe intellectual disability, Severe intellectual disability |
| RS2515417992 |
TTI1
|
Health Risk |
Likely pathogenic |
— |
| RS2515418088 |
TTI1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly and movement abnormalities, Neurodevelopmental disorder with microcephaly and movement abnormalities |
| RS2515419697 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2515421573 |
TNNT1
|
Health Risk |
Pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS2515422575 |
HNF4A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2515422927 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2515424923 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515424995 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515425418 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515425812 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515426073 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2515426768 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2515427372 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2515427481 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2515431543 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515431696 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515432127 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515432357 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515433168 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515433250 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515433373 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515434546 |
CTSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515435428 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515435811 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515440641 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515440663 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515441206 |
CTSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515441270 |
CTSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515441946 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS2515443940 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5B |
| RS2515444704 |
TNNT1
|
Health Risk |
Pathogenic |
Nemaline myopathy 5C, autosomal dominant |
| RS2515445641 |
CTSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515445661 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515447713 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515448551 |
CTSA
|
Health Risk |
Likely pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515448712 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS2515454786 |
PLCB4
|
Health Risk |
Likely pathogenic |
— |
| RS2515458116 |
ZNF341
|
Health Risk |
Pathogenic |
— |
| RS2515462014 |
TTI1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly and movement abnormalities, Neurodevelopmental disorder with microcephaly and movement abnormalities |
| RS2515462580 |
MAFB
|
Health Risk |
Likely pathogenic |
— |
| RS2515463612 |
MAFB
|
Health Risk |
Likely pathogenic |
Multicentric carpo-tarsal osteolysis with or without nephropathy, Multicentric carpo-tarsal osteolysis with or without nephropathy |
| RS2515463632 |
MAFB
|
Health Risk |
Pathogenic |
MAFB-related disorder, MAFB-related disorder |
| RS2515463636 |
MAFB
|
Health Risk |
Pathogenic |
— |
| RS2515463659 |
MAFB
|
Health Risk |
Likely pathogenic |
Multicentric carpo-tarsal osteolysis with or without nephropathy, Multicentric carpo-tarsal osteolysis with or without nephropathy |
| RS2515470310 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS2515474466 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS2515479055 |
RIN2
|
Health Risk |
Likely pathogenic |
— |
| RS2515487726 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515489381 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515489787 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515490171 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515491013 |
PLCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Auriculocondylar syndrome 2, Auriculocondylar syndrome 2 |
| RS2515491207 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2515494062 |
IL12RB1
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2515498227 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, TNNI3-related disorder |
| RS2515498269 |
TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2515498567 |
TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2515498921 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515500031 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515500101 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515503651 |
TNNI3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2515504362 |
TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2515505976 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515506277 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515506445 |
RIN2
|
Health Risk |
Pathogenic |
— |
| RS2515506542 |
PANK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515509700 |
ZNF341
|
Health Risk |
Pathogenic |
— |
| RS2515513944 |
ARFGEF2
|
Health Risk |
Pathogenic |
— |
| RS2515519487 |
DNMT3B
|
Health Risk |
Likely pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS2515520453 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515521686 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515521782 |
DNAAF3
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515521969 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515522322 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Hypoprebetalipoproteinemia |
| RS2515522711 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515522749 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515523115 |
DNMT3B
|
Health Risk |
Likely pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS2515528726 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS2515529863 |
DNAAF3;DNAAF3-AS1;TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS2515530148 |
PIGT
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 3, Multiple congenital anomalies-hypotonia-seizures syndrome 3 |
| RS2515530219 |
TASP1
|
Health Risk |
Likely pathogenic |
Suleiman-El-Hattab syndrome, Suleiman-El-Hattab syndrome |
| RS2515535483 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS2515536377 |
DNMT3B
|
Health Risk |
Pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS2515542106 |
ARFGEF2
|
Health Risk |
Likely pathogenic |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS2515543569 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2515543578 |
CHMP4B
|
Health Risk |
Likely pathogenic |
Cataract 31 multiple types, Cataract 31 multiple types |
| RS2515545698 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515545899 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515547820 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia 2 |
| RS2515547984 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2515548244 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2515552360 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS2515552708 |
ASXL1
|
Health Risk |
Pathogenic |
Atypical chronic myeloid leukemia, BCR-ABL1 negative |
| RS2515553570 |
ASXL1
|
Health Risk |
Pathogenic |
— |